| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NeOnc Technologies Hldgs (NASDAQ:NTHI) through any online brokerage.
Other companies in NeOnc Technologies Hldgs’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
NeOnc Technologies Hldgs has a consensus price target of $17.00.
The stock price for NeOnc Technologies Hldgs (NASDAQ: NTHI) is $2.77 last updated October 19, 2026 at 4:20 PM EDT.
There are no upcoming dividends for NeOnc Technologies Hldgs.
NeOnc Technologies Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for NeOnc Technologies Hldgs.
NeOnc Technologies Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
